Amrize (NYSE:AMRZ) Stock Price Crosses Above Fifty Day Moving Average – Time to Sell?

Amrize Ltd (NYSE:AMRZ – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $39.95 and traded as high as $40.42. Amrize shares last traded at $40.2240, with a volume of 5,350,288 shares.

Trending Headlines about Amrize

Here are the key news stories impacting Amrize this week:

  • Positive Sentiment: Q3 earnings exceeded expectations. Amrize reported adjusted earnings of $1.02 per share, above the $0.98 Zacks consensus estimate. Revenue rose approximately 2.2% to $3.77 billion, while net income increased 3.3% year over year. Amrize Q3 earnings surpass estimates
  • Positive Sentiment: Amrize completed its $1 billion share buyback. The company plans to cancel the repurchased shares, reducing its share count and potentially supporting future earnings per share and shareholder returns. Amrize completes share buyback
  • Positive Sentiment: The company declared a $0.11-per-share dividend. Investors of record on November 10 will receive the payment on November 18, adding to the stock’s shareholder-return appeal. Amrize dividend information
  • Neutral Sentiment: Full-year 2026 guidance was updated. Amrize now expects revenue of $12.2 billion to $12.4 billion, reflecting continued inflationary pressure and falling below the $12.51 billion FactSet consensus estimate. The guidance revision offsets some of the positive impact from the quarterly earnings beat. Amrize updates 2026 earnings guidance

Analysts Set New Price Targets

A number of research firms have weighed in on AMRZ. Truist Financial cut their target price on Amrize from $48.00 to $35.00 and set a “hold” rating for the company in a research report on Monday, October 5th. Barclays dropped their price objective on Amrize from $55.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. William Blair set a $40.00 price objective on Amrize in a report on Wednesday, September 2nd. Stephens cut their price objective on Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Wednesday, August 12th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $60.00 target price on shares of Amrize in a research note on Monday, September 21st. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $49.12.

View Our Latest Report on AMRZ

Amrize Price Performance

The business has a 50-day moving average price of $39.79 and a 200 day moving average price of $50.68. The company has a market cap of $23.01 billion, a price-to-earnings ratio of 18.82, a P/E/G ratio of 1.42 and a beta of 0.20. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, hitting the consensus estimate of $1.05. The business had revenue of $3.77 billion during the quarter. Amrize had a return on equity of 9.96% and a net margin of 9.93%. The business’s revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 earnings per share. As a group, research analysts expect that Amrize Ltd will post 2.44 earnings per share for the current fiscal year.

Amrize Announces Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s dividend payout ratio is currently 5.07%.

Insider Buying and Selling

In other news, CEO Jan Jenisch bought 26,000 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was bought at an average cost of $42.47 per share, for a total transaction of $1,104,220.00. Following the completion of the acquisition, the chief executive officer directly owned 1,767,000 shares in the company, valued at $75,044,490. This represents a 1.49% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Baris Oran bought 3,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the transaction, the chief financial officer owned 3,000 shares of the company’s stock, valued at $142,140. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders acquired 48,983 shares of company stock valued at $2,158,755. Company insiders own 0.54% of the company’s stock.

Hedge Funds Weigh In On Amrize

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC lifted its stake in Amrize by 3.7% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock worth $263,371,000 after acquiring an additional 171,622 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich lifted its position in shares of Amrize by 8.8% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company’s stock worth $78,985,000 after purchasing an additional 170,551 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Amrize by 10.4% during the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company’s stock worth $109,609,000 after purchasing an additional 183,900 shares during the period. Amundi boosted its holdings in shares of Amrize by 30.9% during the first quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after purchasing an additional 390,750 shares during the period. Finally, National Pension Service boosted its holdings in shares of Amrize by 7.5% during the second quarter. National Pension Service now owns 1,493,022 shares of the company’s stock worth $79,578,000 after purchasing an additional 103,962 shares during the period.

About Amrize

(Get Free Report)

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.

See Also

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.